{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:24:43Z","timestamp":1790886283740,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu Provincial Medical Innovation Team","award":["CXDT-37"],"award-info":[{"award-number":["CXDT-37"]}]},{"name":"Jiangsu Provincial Key Research and Development Programme","award":["BE2018657"],"award-info":[{"award-number":["BE2018657"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The goal of this study was to assess small bowel motion and explore the feasibility of using peritoneal space (PS) to replace bowel loops (BL) via the dose constraint method to spare the small bowel during intensity-modulated radiotherapy (IMRT) for rectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 24 patients with rectal cancer who underwent adjuvant or neoadjuvant radiotherapy were selected. Weekly repeat CT scans from pre-treatment to the fourth week of treatment were acquired and defined as Plan, 1\u2009W, 2\u2009W, 3\u2009W, and 4\u2009W. The 4 weekly CT scans were co-registered to the Plan CT, BL and PS contours were delineated in all of the scans, an IMRT plan was designed on Plan CT using PS constraint method, and then copied to the 4 weekly CT scans. The dose-volume, normal tissue complication probability (NTCP) of the small bowel and their variations during treatment were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 109 sets of CT scans from 24 patients were acquired, and 109 plans were designed and copied. The BL and PS volumes were 250.3\u2009cc and 1339.3\u2009cc. The V\n                      <jats:sub>15<\/jats:sub>\n                      of BL and PS based plan of pre-treatment were 182.6\u2009cc and 919.0\u2009cc, the shift% of them were 28.9 and 11.3% during treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.000), which was less in the prone position than in the supine position (25.2% vs 32.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.000; 9.9% vs 14.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.000). The NTCP\n                      <jats:sub>C<\/jats:sub>\n                      and NTCP\n                      <jats:sub>A<\/jats:sub>\n                      based plan of pre-treatment were 2.0 and 59.2%, the shift% during treatment were 46.1 and 14.0% respectively. Majority of BL\u2019s D\n                      <jats:sub>max<\/jats:sub>\n                      and V\n                      <jats:sub>15<\/jats:sub>\n                      were meet the safety standard during treatment using PS dose limit method except 3 times (3\/109) of V\n                      <jats:sub>15<\/jats:sub>\n                      and 5 times of D\n                      <jats:sub>max<\/jats:sub>\n                      (5\/109).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study indicated that small bowel motion may lead to uncertainties in its dose volume and NTCP evaluation during IMRT for rectal cancer. The BL movements were significantly greater than PS, and the prone position was significantly less than the supine position. It is feasibility of using PS to replace BL to spare the small bowel, V\n                      <jats:sub>15<\/jats:sub>\n                      \u2009&lt;\u2009830\u2009cc is the dose constraint standard.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-020-01650-z","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T09:04:04Z","timestamp":1598951044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Siyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2019.05.001","volume":"138","author":"DLP Holyoake","year":"2019","unstructured":"Holyoake DLP, Partridge M, Hawkins MA, et al. Systematic review and meta-analysis of small bowel dose\u2013volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy. Radiother Oncol. 2019;138:38\u201344.","journal-title":"Radiother Oncol"},{"issue":"Suppl 6","key":"1650_CR2","doi-asserted-by":"publisher","first-page":"vi81","DOI":"10.1093\/annonc\/mdt240","volume":"24","author":"B Glimelius","year":"2013","unstructured":"Glimelius B, Tiret E, Cervantes A, Arnold D, ESMO Guidelines Working Group. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi81\u20138.","journal-title":"Ann Oncol"},{"issue":"9666","key":"1650_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811\u201320.","journal-title":"Lancet."},{"issue":"17","key":"1650_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.","journal-title":"N Engl J Med"},{"issue":"11","key":"1650_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114\u201323.","journal-title":"N Engl J Med"},{"issue":"16","key":"1650_CR6","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926\u201333.","journal-title":"J Clin Oncol"},{"issue":"22","key":"1650_CR7","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","volume":"26","author":"M Braendengen","year":"2008","unstructured":"Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, P\u00e5hlman L, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26(22):3687\u201394.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1650_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.ijrobp.2009.03.010","volume":"76","author":"K Bruheim","year":"2010","unstructured":"Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2010;76(4):1005\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1650_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1262-8","volume":"14","author":"R Jadon","year":"2019","unstructured":"Jadon R, Higgins E, Hanna L, Evans M, Coles B, Staffurth J. A systematic review of dose volume predictors and constraints for late bowel toxicity following pelvic radiotherapy. Radiat Oncol. 2019;14(1):57.","journal-title":"Radiat Oncol"},{"issue":"3","key":"1650_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","volume":"87","author":"AK Gandhi","year":"2013","unstructured":"Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys. 2013;87(3):542\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1650_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijrobp.2007.06.066","volume":"70","author":"JM Robertson","year":"2008","unstructured":"Robertson JM, Lockman D, Yan D, Wallace M. The dose volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70(2):413\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1650_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0336-5","volume":"10","author":"T Reis","year":"2015","unstructured":"Reis T, Khazzaka E, Welzel G, Wenz F, Hofheinz RD, Mai S. Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose volume cut-off value predicting grade 2-3 diarrhoea. Radiat Oncol. 2015;10(1):30.","journal-title":"Radiat Oncol"},{"issue":"3 Suppl","key":"1650_CR13","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","volume":"76","author":"BD Kavanagh","year":"2010","unstructured":"Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Haken RKT, et al. Radiation dose volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S101\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1650_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ijrobp.2012.09.036","volume":"85","author":"R Banerjee","year":"2013","unstructured":"Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade \u22653 acute toxicity in rectal Cancer patients treated with neoadjuvant Chemoradiation: an independent validation study comparing peritoneal cavity versus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2013;85(5):1225\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1650_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7785\/tcrt.2012.500283","volume":"11","author":"A Chi","year":"2012","unstructured":"Chi A, Nguyen NP, Xu J, Ji M, Tang J, Jin J, et al. Correlation of three different approaches of small bowel delineation and acute lower gastrointestinal toxicity in adjuvant pelvic intensity-modulated radiation therapy for endometrial cancer. Technol Cancer Res T. 2012;11(4):353\u20139.","journal-title":"Technol Cancer Res T"},{"issue":"5","key":"1650_CR16","first-page":"1225","volume":"85","author":"B Robyn","year":"2012","unstructured":"Robyn B, Santam C, Ian N, Richie S. Small bowel dose parameters predicting grade \u22653 acute toxicity in rectal Cancer patients treated with neoadjuvant Chemoradiation: an independent validation study comparing peritoneal cavity versus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2012;85(5):1225\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1650_CR17","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","volume":"83","author":"HA Gay","year":"2012","unstructured":"Gay HA, H Joseph B, Elizabeth O, Walter RB, Issam EN, Rawan A, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):e353\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1650_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74(3):824\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1650_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.6004\/jnccn.2014.0024","volume":"12","author":"M Reyngold","year":"2014","unstructured":"Reyngold M, Niland J, Ter VA, Milne D, Milne BS, Cohen SJ, et al. Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions. J Natl Compr Cancer Netw. 2014;12(2):235\u201343.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"1650_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1278-3218(04)00086-1","volume":"8","author":"J Nuyttens","year":"2004","unstructured":"Nuyttens J, Robertson J, Yan D, Martinez A. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother. 2004;8(5):297\u2013304.","journal-title":"Cancer Radiother"},{"issue":"6","key":"1650_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1088\/0031-9155\/38\/6\/001","volume":"38","author":"S Webb","year":"1993","unstructured":"Webb S, Nahum AE. A model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous disributions of dose and clonogenic cell density. Phys Med Biol. 1993;38(6):653\u201366.","journal-title":"Phys Med Biol"},{"issue":"1","key":"1650_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","volume":"21","author":"C Burman","year":"1991","unstructured":"Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1650_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0360-3016(87)90266-5","volume":"13","author":"JT Lyman","year":"1987","unstructured":"Lyman JT, Wolbarst AB. Optimization of radiation therapy III: a method of assessing complication probabilities from dose volume histograms. Int J Radiat Oncol Biol Phys. 1987;13(1):103\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1650_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.meddos.2008.04.001","volume":"34","author":"L Cella","year":"2009","unstructured":"Cella L, Ciscognetti N, Martin G, Liuzzi R, Punzo G, Solla R, et al. Preoperative radiation treatment for rectal Cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning. Med Dosim. 2009;34(1):75\u201381.","journal-title":"Med Dosim"},{"issue":"2","key":"1650_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijrobp.2006.05.005","volume":"66","author":"LM Tho","year":"2006","unstructured":"Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys. 2006;66(2):505\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR26","unstructured":"Tai Y. Physiology (textbooks for colleges and universities in China, for clinical medicine of 8 years and 7 years). Beijing: People's HealthPublishing House; 2011."},{"issue":"1","key":"1650_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.radonc.2005.06.007","volume":"76","author":"Y Kvinnsland","year":"2005","unstructured":"Kvinnsland Y, Muren LP. The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer. Radiother Oncol. 2005;76(1):43\u20137.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1650_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.radonc.2008.01.015","volume":"88","author":"G Sanguineti","year":"2008","unstructured":"Sanguineti G, Little M, Endres EJ, Sormani MP, Parker BC. Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer. Radiother Oncol. 2008;88(1):95\u2013101.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1650_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijrobp.2007.03.060","volume":"69","author":"EY Huang","year":"2007","unstructured":"Huang EY, Sung CC, Ko SF, Wang CJ, Yang KD. The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry. Int J Radiat Oncol Biol Phys. 2007;69(3):732\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1650_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s12253-018-0436-2","volume":"25","author":"R K\u00f3sz\u00f3","year":"2019","unstructured":"K\u00f3sz\u00f3 R, Varga L, Fodor E, Kah\u00e1n Z, Cserh\u00e1ti A, Hidegh\u00e9ty K, et al. Prone positioning on a belly board decreases rectal and bowel doses in pelvic intensity-modulated radiation therapy (IMRT) for prostate Cancer. Pathol Oncol Res. 2019;25(3):995\u20131002.","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"1650_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00066-017-1107-z","volume":"193","author":"J Koeck","year":"2017","unstructured":"Koeck J, Kromer K, Lohr F, Baack T, Siebenlist K, Mai S, et al. Small bowel protection in IMRT for rectal cancer. Strahlenther Onkol. 2017;193(7):578\u201388.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1650_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13014-018-1023-0","volume":"13","author":"S Sawayanagi","year":"2018","unstructured":"Sawayanagi S, Yamashita H, Ogita M, Kiritoshi T, Nakamoto T, Abe O, et al. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer. Radiat Oncol. 2018;13(1):70.","journal-title":"Radiat Oncol"},{"issue":"2","key":"1650_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.21037\/tcr.2019.11.33","volume":"9","author":"Y Yang","year":"2019","unstructured":"Yang Y, Cai S, Zhao T, Peng Q, Qian J, Tian Y. Effect of prone and supine treatment positions for postoperative treatment of rectal cancer on target dose coverage and small bowel sparing using intensity-modulated radiation therapy. Transl Cancer Res. 2019;9(2):491\u20139.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1650_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13014-015-0524-3","volume":"10","author":"TC Fr\u00f8seth","year":"2015","unstructured":"Fr\u00f8seth TC, Strickert T, Solli KS, Salvesen O, Frykholm G, Reidunsdatter JR. A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients. Radiat Oncol. 2015;10(1):217.","journal-title":"Radiat Oncol"},{"issue":"2","key":"1650_CR35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijrobp.2017.02.005","volume":"98","author":"J Olsen","year":"2017","unstructured":"Olsen J, Moughan J, Myerson R, Abitbol A, Doncals DE, Johnson D, et al. Predictors of radiotherapy-related GI toxicity from anal Cancer DP-IMRT: secondary analysis of NRG oncology RTOG 0529. Int J Radiat Oncol Biol Phys. 2017;98(2):400\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1650_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.radonc.2017.07.005","volume":"124","author":"C Sini","year":"2017","unstructured":"Sini C, Noris Chiorda B, Gabriele P, Sanguineti G, Morlino S, Badenchini F, et al. Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: first quantification of bowel dose-volume effects. Radiother Oncol. 2017;124(2):269\u2013301.","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-020-01650-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T20:35:21Z","timestamp":1630442121000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01650-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01650-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23237\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23237\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23237\/v2","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of The Second Affiliated Hospital of Soochow University (2014047).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}